Global Transdermal Patch Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Transdermal Patch Product Introduction
1.2 Market Segments
1.3 Key Transdermal Patch Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transdermal Patch Market Size Growth Rate by Type
1.4.2 Methyl Salicylate-based Patch
1.4.3 Rivastigmine Transdermal Patch
1.4.4 Fentanyl Transdermal Patch
1.4.5 Nicotine Transdermal Patch
1.4.6 Estradiol Transdermal Patch
1.4.7 Others
1.5 Market by Application
1.5.1 Global Transdermal Patch Market Size Growth Rate by Application
1.5.2 Relieve Pain
1.5.3 Smoking Stopping
1.5.4 Cardiovascular Diseases
1.5.5 Menopausal Syndrome
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Transdermal Patch Industry Impact
1.6.1 How the Covid-19 is Affecting the Transdermal Patch Industry
1.6.1.1 Transdermal Patch Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Transdermal Patch Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Transdermal Patch Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Transdermal Patch Market Size Estimates and Forecasts
2.1.1 Global Transdermal Patch Revenue 2015-2026
2.1.2 Global Transdermal Patch Sales 2015-2026
2.2 Transdermal Patch Market Size by Region: 2020 Versus 2026
2.2.1 Global Transdermal Patch Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Transdermal Patch Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Transdermal Patch Competitor Landscape by Players
3.1 Transdermal Patch Sales by Manufacturers
3.1.1 Transdermal Patch Sales by Manufacturers (2015-2020)
3.1.2 Transdermal Patch Sales Market Share by Manufacturers (2015-2020)
3.2 Transdermal Patch Revenue by Manufacturers
3.2.1 Transdermal Patch Revenue by Manufacturers (2015-2020)
3.2.2 Transdermal Patch Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transdermal Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transdermal Patch Revenue in 2019
3.2.5 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Transdermal Patch Price by Manufacturers
3.4 Transdermal Patch Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Patch Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Patch Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Patch Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Transdermal Patch Market Size by Type (2015-2020)
4.1.1 Global Transdermal Patch Sales by Type (2015-2020)
4.1.2 Global Transdermal Patch Revenue by Type (2015-2020)
4.1.3 Transdermal Patch Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transdermal Patch Market Size Forecast by Type (2021-2026)
4.2.1 Global Transdermal Patch Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal Patch Revenue Forecast by Type (2021-2026)
4.2.3 Transdermal Patch Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transdermal Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Transdermal Patch Market Size by Application (2015-2020)
5.1.1 Global Transdermal Patch Sales by Application (2015-2020)
5.1.2 Global Transdermal Patch Revenue by Application (2015-2020)
5.1.3 Transdermal Patch Price by Application (2015-2020)
5.2 Transdermal Patch Market Size Forecast by Application (2021-2026)
5.2.1 Global Transdermal Patch Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal Patch Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal Patch Price Forecast by Application (2021-2026)
6 North America
6.1 North America Transdermal Patch by Country
6.1.1 North America Transdermal Patch Sales by Country
6.1.2 North America Transdermal Patch Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Transdermal Patch Market Facts & Figures by Type
6.3 North America Transdermal Patch Market Facts & Figures by Application
7 Europe
7.1 Europe Transdermal Patch by Country
7.1.1 Europe Transdermal Patch Sales by Country
7.1.2 Europe Transdermal Patch Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transdermal Patch Market Facts & Figures by Type
7.3 Europe Transdermal Patch Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Transdermal Patch by Region
8.1.1 Asia Pacific Transdermal Patch Sales by Region
8.1.2 Asia Pacific Transdermal Patch Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Transdermal Patch Market Facts & Figures by Type
8.3 Asia Pacific Transdermal Patch Market Facts & Figures by Application
9 Latin America
9.1 Latin America Transdermal Patch by Country
9.1.1 Latin America Transdermal Patch Sales by Country
9.1.2 Latin America Transdermal Patch Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Transdermal Patch Market Facts & Figures by Type
9.3 Central & South America Transdermal Patch Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Transdermal Patch by Country
10.1.1 Middle East and Africa Transdermal Patch Sales by Country
10.1.2 Middle East and Africa Transdermal Patch Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Transdermal Patch Market Facts & Figures by Type
10.3 Middle East and Africa Transdermal Patch Market Facts & Figures by Application
11 Company Profiles
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Corporation Information
11.1.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
11.1.5 Hisamitsu Pharmaceutical Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Johnson & Johnson Transdermal Patch Products Offered
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Transdermal Patch Products Offered
11.3.5 Novartis Recent Development
11.4 UCB Pharma
11.4.1 UCB Pharma Corporation Information
11.4.2 UCB Pharma Description, Business Overview and Total Revenue
11.4.3 UCB Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 UCB Pharma Transdermal Patch Products Offered
11.4.5 UCB Pharma Recent Development
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description, Business Overview and Total Revenue
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Transdermal Patch Products Offered
11.5.5 Mylan Recent Development
11.6 Nitto Denko
11.6.1 Nitto Denko Corporation Information
11.6.2 Nitto Denko Description, Business Overview and Total Revenue
11.6.3 Nitto Denko Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Nitto Denko Transdermal Patch Products Offered
11.6.5 Nitto Denko Recent Development
11.7 Teikoku Seiyaku
11.7.1 Teikoku Seiyaku Corporation Information
11.7.2 Teikoku Seiyaku Description, Business Overview and Total Revenue
11.7.3 Teikoku Seiyaku Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teikoku Seiyaku Transdermal Patch Products Offered
11.7.5 Teikoku Seiyaku Recent Development
11.8 GSK
11.8.1 GSK Corporation Information
11.8.2 GSK Description, Business Overview and Total Revenue
11.8.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GSK Transdermal Patch Products Offered
11.8.5 GSK Recent Development
11.9 Luye Pharma Group
11.9.1 Luye Pharma Group Corporation Information
11.9.2 Luye Pharma Group Description, Business Overview and Total Revenue
11.9.3 Luye Pharma Group Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Luye Pharma Group Transdermal Patch Products Offered
11.9.5 Luye Pharma Group Recent Development
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Description, Business Overview and Total Revenue
11.10.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfizer Transdermal Patch Products Offered
11.10.5 Pfizer Recent Development
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Corporation Information
11.1.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
11.1.5 Hisamitsu Pharmaceutical Recent Development
11.12 Dr Reddy's Laboratories
11.12.1 Dr Reddy's Laboratories Corporation Information
11.12.2 Dr Reddy's Laboratories Description, Business Overview and Total Revenue
11.12.3 Dr Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Dr Reddy's Laboratories Products Offered
11.12.5 Dr Reddy's Laboratories Recent Development
11.13 Bayer
11.13.1 Bayer Corporation Information
11.13.2 Bayer Description, Business Overview and Total Revenue
11.13.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Bayer Products Offered
11.13.5 Bayer Recent Development
11.14 Mundipharma
11.14.1 Mundipharma Corporation Information
11.14.2 Mundipharma Description, Business Overview and Total Revenue
11.14.3 Mundipharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Mundipharma Products Offered
11.14.5 Mundipharma Recent Development
11.15 Lohmann Therapie-Systeme
11.15.1 Lohmann Therapie-Systeme Corporation Information
11.15.2 Lohmann Therapie-Systeme Description, Business Overview and Total Revenue
11.15.3 Lohmann Therapie-Systeme Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Lohmann Therapie-Systeme Products Offered
11.15.5 Lohmann Therapie-Systeme Recent Development
11.16 Beijing Tide Pharmaceutical
11.16.1 Beijing Tide Pharmaceutical Corporation Information
11.16.2 Beijing Tide Pharmaceutical Description, Business Overview and Total Revenue
11.16.3 Beijing Tide Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Beijing Tide Pharmaceutical Products Offered
11.16.5 Beijing Tide Pharmaceutical Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Transdermal Patch Market Estimates and Projections by Region
12.1.1 Global Transdermal Patch Sales Forecast by Regions 2021-2026
12.1.2 Global Transdermal Patch Revenue Forecast by Regions 2021-2026
12.2 North America Transdermal Patch Market Size Forecast (2021-2026)
12.2.1 North America: Transdermal Patch Sales Forecast (2021-2026)
12.2.2 North America: Transdermal Patch Revenue Forecast (2021-2026)
12.2.3 North America: Transdermal Patch Market Size Forecast by Country (2021-2026)
12.3 Europe Transdermal Patch Market Size Forecast (2021-2026)
12.3.1 Europe: Transdermal Patch Sales Forecast (2021-2026)
12.3.2 Europe: Transdermal Patch Revenue Forecast (2021-2026)
12.3.3 Europe: Transdermal Patch Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Transdermal Patch Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Transdermal Patch Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Transdermal Patch Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Transdermal Patch Market Size Forecast by Region (2021-2026)
12.5 Latin America Transdermal Patch Market Size Forecast (2021-2026)
12.5.1 Latin America: Transdermal Patch Sales Forecast (2021-2026)
12.5.2 Latin America: Transdermal Patch Revenue Forecast (2021-2026)
12.5.3 Latin America: Transdermal Patch Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Transdermal Patch Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Transdermal Patch Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Transdermal Patch Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Transdermal Patch Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Transdermal Patch Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transdermal Patch Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of TablesTable 1. Transdermal Patch Market Segments
Table 2. Ranking of Global Top Transdermal Patch Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Transdermal Patch Market Size Growth Rate by Type 2020-2026 (M Units) & (US$ Million)
Table 4. Major Manufacturers of Methyl Salicylate-based Patch
Table 5. Major Manufacturers of Rivastigmine Transdermal Patch
Table 6. Major Manufacturers of Fentanyl Transdermal Patch
Table 7. Major Manufacturers of Nicotine Transdermal Patch
Table 8. Major Manufacturers of Estradiol Transdermal Patch
Table 9. Major Manufacturers of Others
Table 10. COVID-19 Impact Global Market: (Four Transdermal Patch Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Transdermal Patch Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Transdermal Patch Players to Combat Covid-19 Impact
Table 15. Global Transdermal Patch Market Size Growth Rate by Application 2020-2026 (M Units)
Table 16. Global Transdermal Patch Market Size by Region (M Units) & (US$ Million): 2020 VS 2026
Table 17. Global Transdermal Patch Sales by Regions 2015-2020 (M Units)
Table 18. Global Transdermal Patch Sales Market Share by Regions (2015-2020)
Table 19. Global Transdermal Patch Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Transdermal Patch Sales by Manufacturers (2015-2020) (M Units)
Table 21. Global Transdermal Patch Sales Share by Manufacturers (2015-2020)
Table 22. Global Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Transdermal Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Patch as of 2019)
Table 24. Transdermal Patch Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Transdermal Patch Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Transdermal Patch Price (2015-2020) (USD/Unit)
Table 27. Transdermal Patch Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Transdermal Patch Product Type
Table 29. Date of International Manufacturers Enter into Transdermal Patch Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Transdermal Patch Sales by Type (2015-2020) (M Units)
Table 32. Global Transdermal Patch Sales Share by Type (2015-2020)
Table 33. Global Transdermal Patch Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Transdermal Patch Revenue Share by Type (2015-2020)
Table 35. Transdermal Patch Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 36. Global Transdermal Patch Sales by Application (2015-2020) (M Units)
Table 37. Global Transdermal Patch Sales Share by Application (2015-2020)
Table 38. North America Transdermal Patch Sales by Country (2015-2020) (M Units)
Table 39. North America Transdermal Patch Sales Market Share by Country (2015-2020)
Table 40. North America Transdermal Patch Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Transdermal Patch Revenue Market Share by Country (2015-2020)
Table 42. North America Transdermal Patch Sales by Type (2015-2020) (M Units)
Table 43. North America Transdermal Patch Sales Market Share by Type (2015-2020)
Table 44. North America Transdermal Patch Sales by Application (2015-2020) (M Units)
Table 45. North America Transdermal Patch Sales Market Share by Application (2015-2020)
Table 46. Europe Transdermal Patch Sales by Country (2015-2020) (M Units)
Table 47. Europe Transdermal Patch Sales Market Share by Country (2015-2020)
Table 48. Europe Transdermal Patch Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Transdermal Patch Revenue Market Share by Country (2015-2020)
Table 50. Europe Transdermal Patch Sales by Type (2015-2020) (M Units)
Table 51. Europe Transdermal Patch Sales Market Share by Type (2015-2020)
Table 52. Europe Transdermal Patch Sales by Application (2015-2020) (M Units)
Table 53. Europe Transdermal Patch Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Transdermal Patch Sales by Region (2015-2020) (M Units)
Table 55. Asia Pacific Transdermal Patch Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Transdermal Patch Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Transdermal Patch Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Transdermal Patch Sales by Type (2015-2020) (M Units)
Table 59. Asia Pacific Transdermal Patch Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Transdermal Patch Sales by Application (2015-2020) (M Units)
Table 61. Asia Pacific Transdermal Patch Sales Market Share by Application (2015-2020)
Table 62. Latin America Transdermal Patch Sales by Country (2015-2020) (M Units)
Table 63. Latin America Transdermal Patch Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Transdermal Patch Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Transdermal Patch Revenue Market Share by Country (2015-2020)
Table 66. Latin America Transdermal Patch Sales by Type (2015-2020) (M Units)
Table 67. Latin America Transdermal Patch Sales Market Share by Type (2015-2020)
Table 68. Latin America Transdermal Patch Sales by Application (2015-2020) (M Units)
Table 69. Latin America Transdermal Patch Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Transdermal Patch Sales by Country (2015-2020) (M Units)
Table 71. Middle East and Africa Transdermal Patch Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Transdermal Patch Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Transdermal Patch Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Transdermal Patch Sales by Type (2015-2020) (M Units)
Table 75. Middle East and Africa Transdermal Patch Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Transdermal Patch Sales by Application (2015-2020) (M Units)
Table 77. Middle East and Africa Transdermal Patch Sales Market Share by Application (2015-2020)
Table 78. Hisamitsu Pharmaceutical Corporation Information
Table 79. Hisamitsu Pharmaceutical Description and Major Businesses
Table 80. Hisamitsu Pharmaceutical Transdermal Patch Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Hisamitsu Pharmaceutical Product
Table 82. Hisamitsu Pharmaceutical Recent Development
Table 83. Johnson & Johnson Corporation Information
Table 84. Johnson & Johnson Description and Major Businesses
Table 85. Johnson & Johnson Transdermal Patch Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Johnson & Johnson Product
Table 87. Johnson & Johnson Recent Development
Table 88. Novartis Corporation Information
Table 89. Novartis Description and Major Businesses
Table 90. Novartis Transdermal Patch Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Novartis Product
Table 92. Novartis Recent Development
Table 93. UCB Pharma Corporation Information
Table 94. UCB Pharma Description and Major Businesses
Table 95. UCB Pharma Transdermal Patch Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. UCB Pharma Product
Table 97. UCB Pharma Recent Development
Table 98. Mylan Corporation Information
Table 99. Mylan Description and Major Businesses
Table 100. Mylan Transdermal Patch Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Mylan Product
Table 102. Mylan Recent Development
Table 103. Nitto Denko Corporation Information
Table 104. Nitto Denko Description and Major Businesses
Table 105. Nitto Denko Transdermal Patch Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Nitto Denko Product
Table 107. Nitto Denko Recent Development
Table 108. Teikoku Seiyaku Corporation Information
Table 109. Teikoku Seiyaku Description and Major Businesses
Table 110. Teikoku Seiyaku Transdermal Patch Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Teikoku Seiyaku Product
Table 112. Teikoku Seiyaku Recent Development
Table 113. GSK Corporation Information
Table 114. GSK Description and Major Businesses
Table 115. GSK Transdermal Patch Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. GSK Product
Table 117. GSK Recent Development
Table 118. Luye Pharma Group Corporation Information
Table 119. Luye Pharma Group Description and Major Businesses
Table 120. Luye Pharma Group Transdermal Patch Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Luye Pharma Group Product
Table 122. Luye Pharma Group Recent Development
Table 123. Pfizer Corporation Information
Table 124. Pfizer Description and Major Businesses
Table 125. Pfizer Transdermal Patch Production (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Pfizer Product
Table 127. Pfizer Recent Development
Table 128. Teva Pharmaceutical Corporation Information
Table 129. Teva Pharmaceutical Description and Major Businesses
Table 130. Teva Pharmaceutical Transdermal Patch Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Teva Pharmaceutical Product
Table 132. Teva Pharmaceutical Recent Development
Table 133. Dr Reddy's Laboratories Corporation Information
Table 134. Dr Reddy's Laboratories Description and Major Businesses
Table 135. Dr Reddy's Laboratories Transdermal Patch Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Dr Reddy's Laboratories Product
Table 137. Dr Reddy's Laboratories Recent Development
Table 138. Bayer Corporation Information
Table 139. Bayer Description and Major Businesses
Table 140. Bayer Transdermal Patch Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. Bayer Product
Table 142. Bayer Recent Development
Table 143. Mundipharma Corporation Information
Table 144. Mundipharma Description and Major Businesses
Table 145. Mundipharma Transdermal Patch Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. Mundipharma Product
Table 147. Mundipharma Recent Development
Table 148. Lohmann Therapie-Systeme Corporation Information
Table 149. Lohmann Therapie-Systeme Description and Major Businesses
Table 150. Lohmann Therapie-Systeme Transdermal Patch Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 151. Lohmann Therapie-Systeme Product
Table 152. Lohmann Therapie-Systeme Recent Development
Table 153. Beijing Tide Pharmaceutical Corporation Information
Table 154. Beijing Tide Pharmaceutical Description and Major Businesses
Table 155. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 156. Beijing Tide Pharmaceutical Product
Table 157. Beijing Tide Pharmaceutical Recent Development
Table 158. Global Transdermal Patch Sales Forecast by Regions (2021-2026) (M Units)
Table 159. Global Transdermal Patch Sales Market Share Forecast by Regions (2021-2026)
Table 160. Global Transdermal Patch Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 161. Global Transdermal Patch Revenue Market Share Forecast by Regions (2021-2026)
Table 162. North America: Transdermal Patch Sales Forecast by Country (2021-2026) (M Units)
Table 163. North America: Transdermal Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Europe: Transdermal Patch Sales Forecast by Country (2021-2026) (M Units)
Table 165. Europe: Transdermal Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Asia Pacific: Transdermal Patch Sales Forecast by Region (2021-2026) (M Units)
Table 167. Asia Pacific: Transdermal Patch Revenue Forecast by Region (2021-2026) (US$ Million)
Table 168. Latin America: Transdermal Patch Sales Forecast by Country (2021-2026) (M Units)
Table 169. Latin America: Transdermal Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Middle East and Africa: Transdermal Patch Sales Forecast by Country (2021-2026) (M Units)
Table 171. Middle East and Africa: Transdermal Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 173. Key Challenges
Table 174. Market Risks
Table 175. Main Points Interviewed from Key Transdermal Patch Players
Table 176. Transdermal Patch Customers List
Table 177. Transdermal Patch Distributors List
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of FiguresFigure 1. Transdermal Patch Product Picture
Figure 2. Global Transdermal Patch Sales Market Share by Type in 2020 & 2026
Figure 3. Methyl Salicylate-based Patch Product Picture
Figure 4. Rivastigmine Transdermal Patch Product Picture
Figure 5. Fentanyl Transdermal Patch Product Picture
Figure 6. Nicotine Transdermal Patch Product Picture
Figure 7. Estradiol Transdermal Patch Product Picture
Figure 8. Others Product Picture
Figure 9. Global Transdermal Patch Sales Market Share by Application in 2020 & 2026
Figure 10. Relieve Pain
Figure 11. Smoking Stopping
Figure 12. Cardiovascular Diseases
Figure 13. Menopausal Syndrome
Figure 14. Others
Figure 15. Transdermal Patch Report Years Considered
Figure 16. Global Transdermal Patch Market Size 2015-2026 (US$ Million)
Figure 17. Global Transdermal Patch Sales 2015-2026 (M Units)
Figure 18. Global Transdermal Patch Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Transdermal Patch Sales Market Share by Region (2015-2020)
Figure 20. Global Transdermal Patch Sales Market Share by Region in 2019
Figure 21. Global Transdermal Patch Revenue Market Share by Region (2015-2020)
Figure 22. Global Transdermal Patch Revenue Market Share by Region in 2019
Figure 23. Global Transdermal Patch Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Transdermal Patch Revenue in 2019
Figure 25. Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Transdermal Patch Sales Market Share by Type (2015-2020)
Figure 27. Global Transdermal Patch Sales Market Share by Type in 2019
Figure 28. Global Transdermal Patch Revenue Market Share by Type (2015-2020)
Figure 29. Global Transdermal Patch Revenue Market Share by Type in 2019
Figure 30. Global Transdermal Patch Market Share by Price Range (2015-2020)
Figure 31. Global Transdermal Patch Sales Market Share by Application (2015-2020)
Figure 32. Global Transdermal Patch Sales Market Share by Application in 2019
Figure 33. Global Transdermal Patch Revenue Market Share by Application (2015-2020)
Figure 34. Global Transdermal Patch Revenue Market Share by Application in 2019
Figure 35. North America Transdermal Patch Sales Growth Rate 2015-2020 (M Units)
Figure 36. North America Transdermal Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Transdermal Patch Sales Market Share by Country in 2019
Figure 38. North America Transdermal Patch Revenue Market Share by Country in 2019
Figure 39. U.S. Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 40. U.S. Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 42. Canada Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Transdermal Patch Market Share by Type in 2019
Figure 44. North America Transdermal Patch Market Share by Application in 2019
Figure 45. Europe Transdermal Patch Sales Growth Rate 2015-2020 (M Units)
Figure 46. Europe Transdermal Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Transdermal Patch Sales Market Share by Country in 2019
Figure 48. Europe Transdermal Patch Revenue Market Share by Country in 2019
Figure 49. Germany Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 50. Germany Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 52. France Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 54. U.K. Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 56. Italy Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 58. Russia Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Transdermal Patch Market Share by Type in 2019
Figure 60. Europe Transdermal Patch Market Share by Application in 2019
Figure 61. Asia Pacific Transdermal Patch Sales Growth Rate 2015-2020 (M Units)
Figure 62. Asia Pacific Transdermal Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Transdermal Patch Sales Market Share by Region in 2019
Figure 64. Asia Pacific Transdermal Patch Revenue Market Share by Region in 2019
Figure 65. China Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 66. China Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 68. Japan Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 70. South Korea Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 72. India Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 74. Australia Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 76. Taiwan Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 78. Indonesia Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 80. Thailand Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure 82. Malaysia Transdermal Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Transdermal Patch Sales Growth Rate (2015-2020) (M Units)
Figure